{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:59:33Z","timestamp":1785365973058,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003441","name":"Universitair Ziekenhuis Gent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cmi.2025.11.035","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:26:06Z","timestamp":1764721566000},"page":"466-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Model-based optimisation for teicoplanin dosing in patients undergoing maintenance haemodialysis"],"prefix":"10.1016","volume":"32","author":[{"given":"Sebastian T.","family":"Tandar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda B.S.","family":"Aulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Van Biesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurd","family":"Delanghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris","family":"Vanommeslaeghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"De Paepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.G. Coen","family":"van Hasselt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter A.","family":"De Cock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Eloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2025.11.035_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2215\/CJN.06820619","article-title":"Prevention of bloodstream infections in patients undergoing hemodialysis","volume":"15","author":"Fisher","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2025.11.035_bib2","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2215\/CJN.0000000000000476","article-title":"A six-year follow-up of bloodstream infections in hemodialysis facilities in the United States, National Healthcare Safety Network, 2020","volume":"19","author":"Keenan","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2025.11.035_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jac\/23.4.613","article-title":"Serum and tissue levels of teicoplanin during cardiac surgery: the effect of a high dose regimen","volume":"23","author":"Wilson","year":"1989","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.11.035_bib4","series-title":"The renal drug handbook","author":"Ashley","year":"2018"},{"key":"10.1016\/j.cmi.2025.11.035_bib5","series-title":"Teicoplanine: Commissie analyse & toxicologie van de Nederlandse Vereniging van Ziekenhuisapothekers","author":"Moorlag","year":"2016"},{"key":"10.1016\/j.cmi.2025.11.035_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s40262-025-01483-7","article-title":"Pharmacokinetics and target attainment of teicoplanin: a systematic review","volume":"64","author":"Mouton","year":"2025","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2025.11.035_bib7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s40262-021-01040-y","article-title":"Antimicrobial dose reduction in continuous renal replacement therapy: Myth or real need? A practical approach for guiding dose optimization of novel antibiotics","volume":"60","author":"Gatti","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2025.11.035_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40262-020-00945-4","article-title":"Population pharmacokinetics of unbound and total teicoplanin in critically ill pediatric patients","volume":"60","author":"Aulin","year":"2021","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cmi.2025.11.035_bib9","doi-asserted-by":"crossref","first-page":"dlab012","DOI":"10.1093\/jacamr\/dlab012","article-title":"Evaluation of a thrice weekly administration of teicoplanin in the outpatient setting: a retrospective observational multicentre study","volume":"3","author":"Asumang","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.cmi.2025.11.035_bib10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ijantimicag.2015.05.019","article-title":"Teicoplanin use in adult patients with haematological malignancy: Exploring relationships between dose, trough concentrations, efficacy and nephrotoxicity","volume":"46","author":"Byrne","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2025.11.035_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clinbiochem.2018.12.010","article-title":"Development and validation of an ultra-high performance liquid chromatography\u2014high resolution mass spectrometry method for the quantification of total and free teicoplanin in human plasma","volume":"65","author":"Deltombe","year":"2019","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cmi.2025.11.035_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40360-016-0048-y","article-title":"Three-times-weekly, post-dialysis cefepime therapy in patients on maintenance hemodialysis: a retrospective study","volume":"17","author":"Descombes","year":"2016","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.cmi.2025.11.035_bib13","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/jac\/dkx242","article-title":"Population pharmacokinetics of teicoplanin administered by subcutaneous or intravenous route and simulation of optimal loading dose regimen","volume":"72","author":"Cazaubon","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.cmi.2025.11.035_bib14","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.3390\/toxins7103933","article-title":"Exploring protein binding of uremic toxins in patients with different stages of chronic kidney disease and during hemodialysis","volume":"7","author":"Deltombe","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cmi.2025.11.035_bib15","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2215\/CJN.00340118","article-title":"Clinical pharmacokinetics in kidney disease: fundamental principles","volume":"13","author":"Lea-Henry","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.cmi.2025.11.035_bib16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s00134-003-1914-9","article-title":"Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration","volume":"29","author":"Yagasaki","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cmi.2025.11.035_bib17","first-page":"243","article-title":"Teicoplanin pharmacokinetics in critically ill patients on continuous veno-venous hemofiltration","volume":"48","author":"Bellmann","year":"2010","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.cmi.2025.11.035_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/hdi.12704","article-title":"High variability of teicoplanin concentration in patients with continuous venovenous hemodiafiltration","volume":"23","author":"Lim","year":"2019","journal-title":"Hemodial Int"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2500607X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X2500607X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:20:57Z","timestamp":1785363657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X2500607X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1198743X2500607X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2025.11.035","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Model-based optimisation for teicoplanin dosing in patients undergoing maintenance haemodialysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2025.11.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}